Ignite Creation Date:
2024-05-06 @ 9:34 AM
Last Modification Date:
2024-10-26 @ 12:16 PM
Study NCT ID:
NCT03013543
Status:
COMPLETED
Last Update Posted:
2023-08-18
First Post:
2017-01-03
Brief Title:
Setmelanotide Phase 2 Treatment Trial in Participants With Rare Genetic Disorders of Obesity
Sponsor:
Rhythm Pharmaceuticals Inc
Organization:
Rhythm Pharmaceuticals Inc
Organization Data
Organization:
Rhythm Pharmaceuticals Inc
Class:
INDUSTRY
Study ID:
RM-493-014
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Rhythm Pharmaceuticals Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None